Get started
Author

Chenyang Zhang

Suppression of outward K+ currents by WIN55212-2 in rat retinal ganglion cells is independent of CB1/CB2 receptors
2013 · C.-Q. Zhang, H.-J. Wu, et al. · Neuroscience · 19
Characterization of an Enhancer RNA Signature Reveals Treatment Strategies for Improving Immunotherapy Efficacy in Cancer
2025 · Chenyang Zhang, Yan-Yan Chen, et al. · Cancer Research · 6
Dual‐Energy CT Demonstrates Multiple Urate Crystal Deposits in the Sternoclavicular Joint, Cricoid Cartilage, and Cervical Ligaments
2025 · Chenyang Zhang, Ziyu Wang, et al. · Clinical Case Reports · 1
PDF
Comprehensive characterization of transposable element expression reveals regulatory circuitry and clinical implications in cancers
2026 · Wei Hu, Wenjun Jiang, et al. · Science Advances
Supplementary Table 2 from Characterization of an Enhancer RNA Signature Reveals Treatment Strategies for Improving Immunotherapy Efficacy in Cancer
2026 · Chenyang Zhang, Yan-Yan Chen, et al.
Supplementary Table 4 from Characterization of an Enhancer RNA Signature Reveals Treatment Strategies for Improving Immunotherapy Efficacy in Cancer
2026 · Chenyang Zhang, Yan-Yan Chen, et al.
Figure S8 from Characterization of an Enhancer RNA Signature Reveals Treatment Strategies for Improving Immunotherapy Efficacy in Cancer
2026 · Chenyang Zhang, Yan-Yan Chen, et al.
Figure S5 from Characterization of an Enhancer RNA Signature Reveals Treatment Strategies for Improving Immunotherapy Efficacy in Cancer
2026 · Chenyang Zhang, Yan-Yan Chen, et al.
Figure S3 from Characterization of an Enhancer RNA Signature Reveals Treatment Strategies for Improving Immunotherapy Efficacy in Cancer
2026 · Chenyang Zhang, Yan-Yan Chen, et al.
Figure S1 from Characterization of an Enhancer RNA Signature Reveals Treatment Strategies for Improving Immunotherapy Efficacy in Cancer
2026 · Chenyang Zhang, Yan-Yan Chen, et al.
Figure S7 from Characterization of an Enhancer RNA Signature Reveals Treatment Strategies for Improving Immunotherapy Efficacy in Cancer
2026 · Chenyang Zhang, Yan-Yan Chen, et al.
Supplementary Table 5 from Characterization of an Enhancer RNA Signature Reveals Treatment Strategies for Improving Immunotherapy Efficacy in Cancer
2026 · Chenyang Zhang, Yan-Yan Chen, et al.
Supplementary Table 1 from Characterization of an Enhancer RNA Signature Reveals Treatment Strategies for Improving Immunotherapy Efficacy in Cancer
2026 · Chenyang Zhang, Yan-Yan Chen, et al.
Figure S2 from Characterization of an Enhancer RNA Signature Reveals Treatment Strategies for Improving Immunotherapy Efficacy in Cancer
2026 · Chenyang Zhang, Yan-Yan Chen, et al.
Figure S4 from Characterization of an Enhancer RNA Signature Reveals Treatment Strategies for Improving Immunotherapy Efficacy in Cancer
2026 · Chenyang Zhang, Yan-Yan Chen, et al.
Supplementary Table 3 from Characterization of an Enhancer RNA Signature Reveals Treatment Strategies for Improving Immunotherapy Efficacy in Cancer
2026 · Chenyang Zhang, Yan-Yan Chen, et al.
Figure S6 from Characterization of an Enhancer RNA Signature Reveals Treatment Strategies for Improving Immunotherapy Efficacy in Cancer
2026 · Chenyang Zhang, Yan-Yan Chen, et al.
Figure S9 from Characterization of an Enhancer RNA Signature Reveals Treatment Strategies for Improving Immunotherapy Efficacy in Cancer
2026 · Chenyang Zhang, Yan-Yan Chen, et al.
Data from Characterization of an Enhancer RNA Signature Reveals Treatment Strategies for Improving Immunotherapy Efficacy in Cancer
2025 · Chenyang Zhang, Yan-Yan Chen, et al.
Figure S1 from Characterization of an Enhancer RNA Signature Reveals Treatment Strategies for Improving Immunotherapy Efficacy in Cancer
2025 · Chenyang Zhang, Yan-Yan Chen, et al.
PDF
Figure S4 from Characterization of an Enhancer RNA Signature Reveals Treatment Strategies for Improving Immunotherapy Efficacy in Cancer
2025 · Chenyang Zhang, Yan-Yan Chen, et al.
PDF
Figure S2 from Characterization of an Enhancer RNA Signature Reveals Treatment Strategies for Improving Immunotherapy Efficacy in Cancer
2025 · Chenyang Zhang, Yan-Yan Chen, et al.
PDF
Figure S5 from Characterization of an Enhancer RNA Signature Reveals Treatment Strategies for Improving Immunotherapy Efficacy in Cancer
2025 · Chenyang Zhang, Yan-Yan Chen, et al.
PDF
Figure S3 from Characterization of an Enhancer RNA Signature Reveals Treatment Strategies for Improving Immunotherapy Efficacy in Cancer
2025 · Chenyang Zhang, Yan-Yan Chen, et al.
PDF
Figure S6 from Characterization of an Enhancer RNA Signature Reveals Treatment Strategies for Improving Immunotherapy Efficacy in Cancer
2025 · Chenyang Zhang, Yan-Yan Chen, et al.
PDF
Works count: 34
Citation count: 26
H-index: 2
I10-index: 1
Year
Topic
Type